We are live on ! Find out more
GENE

Genetic Technologies Ltd.
GENE

Delisted

GENE was delisted on the 16th of October, 2024.

Back to rankings

2 hedge funds and large institutions have $2.03K invested in Genetic Technologies Ltd. in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

0% more capital invested

Capital invested by funds: $2.03K → $2.03K ($0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
1
RhumbLine Advisers
Massachusetts
$2.03K – – –

GENE Hedge Fund Activity: Q4 2025 in Review

2 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q4 2025, worth a combined $2.03K — unchanged from a quarter earlier.

Fund positioning in GENE was balanced in Q4 2025: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held Genetic Technologies Ltd. (GENE) as of Q4 2025, unchanged from Q3 2025.
  • Funds reported $2.03K of Genetic Technologies Ltd. stock for Q4 2025, unchanged quarter-over-quarter.
  • 1 fund opened new Genetic Technologies Ltd. positions in Q4 2025 and 1 closed out, a net change of 0 holders.

Based on aggregated 13F filings for Q4 2025.